Previous studies have demonstrated that, contrarily to LOXL2, LOXL4 overexpression has an inhibitory effect on cancer proliferation and progression-related events in different cancer models (Wu et al., 2007; Choi et al., 2017; Shao et al., 2019). The gene discussed is LOXL4; the disease is cancer.